New study tracks how postpartum depression symptoms change with zuranolone
NCT ID NCT07398469
First seen Feb 28, 2026 · Last updated May 23, 2026 · Updated 7 times
Summary
This study follows 200 people with postpartum depression (PPD) who have a new prescription for zuranolone. Researchers will use online surveys to track changes in depression symptoms 15, 45, and 90 days after starting the medication. The goal is to better understand how symptoms improve over time in real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Biogen
RECRUITINGCambridge, Massachusetts, 02142, United States
Contact
Conditions
Explore the condition pages connected to this study.